NasdaqCM:VKTXBiotechs
Viking Therapeutics (VKTX) Appoints Dorothy Gemmell To Board As Commercial Focus Grows
Viking Therapeutics (NasdaqCM:VKTX) has appointed healthcare executive Dorothy Gemmell to its Board of Directors.
Gemmell brings leadership experience across healthcare, digital health, and commercial execution for high growth companies.
The board change is viewed as a material governance development for the company as it advances its pipeline.
Viking Therapeutics enters this board transition with its stock at $35.39 and very large 3 year and 5 year share price gains, alongside a 5.6%...